Precision medicine represents both a business and clinical opportunity for multiple healthcare stakeholders. At times of significant healthcare challenges, it is a clear means of combining emerging technologies with in-depth disease understanding to deliver better care to patients. Pharmaceutical companies can seize this opportunity — or ignore it and watch their competitors pass them by.
© 2019 - 2025 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.